Nationwide seroprevalence of antibodies to SARS-CoV-2 in asymptomatic population in South Korea: a cross-sectional study.
Eun Hee NahSeon ChoHyeran ParkInhwan HwangHan-Ik ChoPublished in: BMJ open (2021)
Most of the Korean population is still immunologically vulnerable to SARS-CoV-2, but the seroprevalence has increased relative to that found in studies performed prior to September 2020 in Korea.